Ocular Therapeutix accelerates timelines for SOL-1 Phase 3 trial of Axpaxli for wet AMD
The study is now expected to be fully enrolled with all 300 patients randomized by the end of 2024.
The power of social media: Attracting younger generations to your practice
Showcasing your practice’s eyewear collections plays a huge role in your success and helps differentiate you from your competitors.
The white cane and beyond
Navigation and orientation technologies offer practical solution for people with vision loss.
RetinaLyze System A/S unveils AI to aid in the early detection of glaucoma
As much as 96% of customers and 60% of patients can get their results in less than a minute with Retinalyze, according to the company.
Rising diabetic retinopathy rates in youth could indicate potential public health crisis
A recent paper sparks concerns over inadequate screening and management, especially among Black and Hispanic youths, according to its authors.
My journey into behavioral optometry
Relationship between the brain and vision took center stage at 2024 International Congress of Behavioral Optometry.
A glasses-wearing kitty?: Truffles and her impact on eye care, one pediatric patient at a time
Danielle Crull, ABOM, details Truffles' story and new initiatives she has taken on to destigmatize glasses and patching for children.
The AOA Foundation raises over $200,000 for optometrists affected by Hurricanes Helene and Milton
According to the American Optometric Association, there are more than 7700 licensed practicing optometrists in 6 states affected by the hurricanes.
That’s some nerve! Ocular drug delivery and dry eye
There’s more to dry eye treatment than eye drops.
FDA approves enVista Envy IOL from Bausch + Lomb
The enVista Envy IOL offers a full range of vision, and 86% of patients in clinical trial reported little or no trouble with dysphotopsia.
How eye care gets ahead in rural communities
With transportation hurdles, lack of eye care providers and practices, and economic disadvantages working against rural patients, vision initiatives are getting creative to ensure they still receive care.
What happened in optometry this week: October 7 - October 11
Catch up on what happened in optometry during the week of October 7-October 11.
Espansione Group announces new AI-powered algorithm for meibomian gland segmentation
MeiboMetrics is scheduled to be available on several platforms starting in 2025.
A glasses-wearing kitty?: What contributes to Truffles' success
Danielle Crull, ABOM, of A Child's Eyes discusses what is now possible at her glasses dispensary that was not previously possible without Truffles.
World Sight Day 2024: Experts discuss potential impact of AI in diagnostics and screening
On World Sight Day, leading experts in ophthalmology look at artificial intelligence and how it could impact diagnosing and finding diseases in the future.
A glasses-wearing kitty?: Getting to know Truffles
Truffles the Kitty has helped put A Child's Eyes patients feel more at ease when being fitted with glasses while taking social media by storm.
Orasis Pharmaceuticals secures financing for commercial launch of presbyopia-correcting drops
You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO
Justin Kwan, OD, FAAO, shares his journey from optometrist to myopia management advocate and provides some tips for getting started on your own journey.
MJH Life Sciences acquires EnVision Summit
The Eye Care Network adds a longstanding, CME-certified to its live event programming.
Study finds common mechanistic defect and potential therapies for AMD and related macular dystrophies
Related macular dystrophies (MDs) include Sorsby’s fundus dystrophy, Doyne honeycomb macular dystrophy, and autosomal dominant radial drusen.